Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer

Stopped early · Phase 2

Conditions studied: Locally Advanced Cervical Cancer

In brief

The purpose of this study is to determine whether SABR boost therapy is effective in women with locally advanced cervical cancer without increased risk of acute gastrointestinal (GI) or genitourinary (GU) toxicity.

Key facts

Study ID

NCT02045433

Run by

University of Texas Southwestern Medical Center

People needed

16

Starts

2014-03-27

Expected to finish

2018-11-04

Last updated by the study team

2020-08-21

Who can join

Age: 18 and older, up to 99. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• 1 Locally Advanced stage Cervical Cancer 2. Zubrod performance status 0-2 3. Negative urine or serum pregnancy test for women of child-bearing potential 4. Agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry and for the duration of study treatment 5. Not a candidate for intracavitary brachytherapy

You may not qualify if…

• Pregnancy
• Concurrent untreated cancer excluding non-Melanoma skin cancer
• Previous pelvic radiation
• Active Inflammatory Bowel disease, Collagen vascular disease - systemic lupus erythematosus (SLE), scleroderma
• Age <18
• Unable to consent for study
• Severely immunocompromised patients ( such as Transplant , on immunosuppressive drugs)

Where it is running

• University of Texas Southwestern Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.